We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.05 | 0.20 | 0.125 | 0.125 | 0.13 | 4,085,813 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.59M | -1.69M | -0.0037 | -0.32 | 544.67k |
Date | Subject | Author | Discuss |
---|---|---|---|
07/4/2021 22:29 | 1gw, "On product revenue, I think they did about £1.1m/month in 1Q (Apr-Jun) and £0.9m/month in 2Q (Jul-Sep). In 2HFY20 they did around £0.5m/month, or just £0.4m/month in the first 5 months before a blowout March when they did £1m." That's completely opposite of what you were saying before. I repeatedly said that sales have slowed down and the evidence was lack of TUs stating 'record sales', lack of sales at Boots, homeandcleaning etc. Points of mine which you readily ridiculed. ;-) So you're now not expecting £17m revenues?? lol sikhthetech4 Feb '21 - 14:16 - 7527 of 7898 Edit 1gw, During the early months of covid, there were regular monthly TU comments about 'selling as much as they can make', '£1m+ per month', 'record sales'. Despite those regular TUs, their sales increased by only £4m for H1, Apr to Sept. Therefore, there was a lull during summer, as expected. The lack of TUs saying similar says a lot, so best wait to see what they say. | sikhthetech | |
07/4/2021 21:21 | I would hope they can manage YoY growth, but other than that I have no particular insight. I think internally they manage the business to profit (adj EBITDA) rather than revenue so I'm not sure they'd feel obliged to tell us if revenue was going to be materially adrift of the finnCap forecast, as long as profit was broadly in line. On product revenue, I think they did about £1.1m/month in 1Q (Apr-Jun) and £0.9m/month in 2Q (Jul-Sep). In 2HFY20 they did around £0.5m/month, or just £0.4m/month in the first 5 months before a blowout March when they did £1m. So I would expect them to comfortably beat the 2HFY20 number. I think the finnCap forecast has them at £0.8m/month in 2H (£4.8m for 2H, £11.5m total revenue for FY21) with virtually no royalty revenue. So in 2H numbers I think, apart from the actual headline numbers, the interest will be in how much royalty comes through - can they say anything about SC Johnson, IRI, Solvay, Tristel - did any get meaningfully above the minimum guaranteed levels that have already been booked? In the detail, it will be interesting to see what they say about any brexit-related stockpiling or supply chain troubles and what they say about restocking ahead of the opening up of the economy. Also on the consumer side how has the expanded Boots relationship gone? I am more interested in what if any guidance or commentary they (or finnCap) can give on this year. What level of product sales do they see as sustainable as things (hopefully) normalise and what if anything can they say about royalty/commission expectations? And of course, it would be nice to have another licence deal or two announced to get the year off to a flying start. | 1gw | |
07/4/2021 19:52 | What do we reckon for 2h revenue, continued growth YOY? | the ghost who walks | |
07/4/2021 19:35 | As Tristel stated in their Q&A only a few months ago (Sept 2020), the product is unique from a chemistry prospective but whether it will be a commercial success, will take a long time to determine. Tstl stated the position perfectly regarding tech and commercial success. "The challenge we face with our partner Byotrol is essentially one of marketing communication: messaging. Today, UK hospitals use Jet because it is a high-performance, fast-acting biocide, effective against bacterial spores and compliant with every European legal requirement for disinfectants within one standard contact time of 1 minute, that is easy and convenient to use, and priced competitively to pre-wetted wipes incorporating far less effective disinfectant chemistries." "The intermediate level disinfectant formulation that has also been licensed from Byotrol will sit in one or more of the Cache Collection SKUs, alongside other formulation offers that come from our own stable of non-CLO2 chemistries. The Byotrol intermediate level formulation is very well-documented and supported by their technical team. " "We are enthusiastic for the combinatorial proposition but it is important that we set expectations sensibly (we follow with interest the excitable dialogue on the share chat rooms): this is not a gamechanging technological advance for Tristel plc. The grounded truth is that with our partner Byotrol we have created something unique from a chemistry perspective" " The commercial success of that proposition will take a long time to determine." | sikhthetech | |
07/4/2021 16:28 | Predictions for 2h revenue? | the ghost who walks | |
07/4/2021 16:25 | bid coming | onehanded | |
07/4/2021 14:01 | 6.45 buy now | football | |
07/4/2021 12:48 | Did have some doubts myself but it sort of fitted our search. Its quite a complicated eco system I suppose you want to take market share from competitors and like you say not risk diluting sales in existing offerings.Maybe we get the hard launch when all the dots are aligned and "actizone" on the label commands a premium.Till then...will keep em peeled. | riddlerone | |
07/4/2021 12:30 | Well done for finding this one riddlerone. I've looked and looked for a 24hour Henkel product and didn't come across it. I can only think Henkel are perhaps keeping it deliberately low-key to start with (if it is a new product), whether or not it's an Actizone-based product, maybe to test consumer enthusiasm before risking promotion that might cannibalise existing sales of other products. | 1gw | |
07/4/2021 12:27 | Don't know. The date for "first available on Amazon" of 15th October 2020 seems to fit with Solvay launch, but apart from the lack of 24 hour virus claim it requires 15 minutes soaking (I would have thought Actizone was 5 minutes soak for 24hr claim, same as byotrol 4-in-1) and doesn't seem to mention Actizone anywhere on the label, although I can't find a very good image of the label. I can't find any evidence of a launch press release. | 1gw | |
07/4/2021 08:55 | It fits the profile apart from the 24 hour claim seems only for bacteria so similar to microban. | riddlerone | |
07/4/2021 08:28 | Is this the Henkel product we have been waiting for,its definately new. | riddlerone | |
06/4/2021 13:39 | fao:sikhthetec. Tortoise and the hare | trcml | |
05/4/2021 22:53 | Good old STD bought in to TLY at £3ish and now 30p ish Runs a Care Home and now will get sued once this is all over for not having enough PPE to look after the vulnerable in it | football | |
05/4/2021 19:54 | They were presented with the biggest opportunity ever possible on a plate. Their H1 results were disappointing and there's been a lack of PR, Marketing and TU. From their H1-2021 accounts published Dec. Rest is jam tomorrow. £590k (yes k) increase in global consumer sales during H1 (Apr-Sept) when there's the biggest pandemic to hit the globe is not impressive. So with the biggest pandemic to strike in a century they managed £997k (ex-royalty & licensing) of consumer sales! That includes Boots, Homeandcleaning, direct website sales, global sales. Other companies have taken advantage of the huge opportunity presented and entered the market. As expected. | sikhthetech | |
05/4/2021 08:46 | Sorry if these have been posted before here's a link to one of their partners way before the funding was announced They are also a PHD Industrial partner for Liverpool Uni | riddlerone | |
05/4/2021 08:25 | Been saying for a while the seaweed thing is going to be big for us. I think we get an update at half year | the ghost who walks | |
03/4/2021 17:01 | "Alongside other automotive industry leaders Shell Lubricants US and Turtle Wax Inc, Purolator will help bring vehicle hygiene solutions to the automotive industry at scale." "We’re really pleased to see Move Clean continue to expand and enhance their vehicle hygiene offer to protect more drivers and riders across the country..." These extracts from the Purolator collaboration article (same page as previous post) suggest things are ramping up with Move Clean and it's great to see the reference to "at scale". Move Clean itself seems very quiet though - difficult to find much about locations at which it is on offer or service partners who are offering it. | 1gw | |
03/4/2021 16:48 | hTTps://yaledailynew | football | |
03/4/2021 16:37 | "Shell and Turtle Wax were developing a new venture, Move Clean, well before the pandemic. The timeline of its launch just happened to coincide with the arrival of COVID. " That's an interesting statement (from the "When COVID Leaves, Cleaning Should Stay" article) in the context of trying to work out when Turtle Wax and IRI/byotrol first got serious about a licence deal. It suggests that Turtle Wax and Shell were working on Move Clean well before the byotrol-IRI licence deal was announced. So what Turtle Wax product were TW and Shell planning to use, or did they already have B24 in mind? Did IRI persuade TW to switch to the byotrol product, perhaps from the one that TW had previously marketed under the "Defend-X" brand? | 1gw | |
03/4/2021 09:46 | "THIS is the moment a commuter was seen DRINKING hand sanitiser at a Scots train station." | riddlerone |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions